You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 12, June 23, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (36)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Chronic Obstructive Pulmonary Disease
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Low Lung Function and Incident Lung Cancer in the United States

Data From the First National Health and Nutrition Examination Survey Follow-up

David M. Mannino, MD; Samuel M. Aguayo, MD; Thomas L. Petty, MD; Stephen C. Redd, MD

Arch Intern Med. 2003;163:1475-1480.

Background  Obstructive lung disease and lung cancer are tobacco-related diseases that can remain clinically silent until late in the disease process. We sought to define the risk for incident lung cancer among a national cohort of US adults with and without obstructive lung disease.

Methods  We studied participants in the First National Health and Nutrition Examination Survey, who had up to 22 years of follow-up. We classified subjects as having moderate or severe obstructive lung disease at baseline if the ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) was less than 70% and the FEV1 was less than 80% of the predicted value. We also determined incident cases of lung cancer during the follow-up period.

Results  A total of 113 lung cancers occurred in the 5402 adults in the cohort. In the proportional hazards model adjusted for covariates of age, sex, race, education, smoking status, and duration and intensity of smoking, the presence of moderate or severe obstructive lung disease was associated with a higher risk for incident lung cancer (hazard ratio, 2.8; 95% confidence interval, 1.8-4.4).

Conclusions  The presence of moderate or severe obstructive lung disease is a significant predictor of incident lung cancer in long-term follow-up. This finding may be useful clinically and in studies evaluating the utility of new tools for the early detection of lung cancer.


From the Air Pollution and Respiratory Health Branch, Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Ga (Drs Mannino and Redd); the Veterans Administration Medical Center, Decatur, Ga (Dr Aguayo); and Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colo (Dr Petty). The authors have no relevant financial interest in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

COPD and cancer mortality: the influence of statins
van Gestel et al.
Thorax 2009;64:963-967.
ABSTRACT | FULL TEXT  

A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers
Young et al.
Postgrad. Med. J. 2009;85:515-524.
ABSTRACT | FULL TEXT  

Matrix Metalloproteinase 12 Overexpression in Lung Epithelial Cells Plays a Key Role in Emphysema to Lung Bronchioalveolar Adenocarcinoma Transition
Qu et al.
Cancer Res. 2009;69:7252-7261.
ABSTRACT | FULL TEXT  

COPD prevalence is increased in lung cancer, independent of age, sex and smoking history
Young et al.
Eur Respir J 2009;34:380-386.
ABSTRACT | FULL TEXT  

Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence
Young et al.
Postgrad. Med. J. 2009;85:414-421.
ABSTRACT | FULL TEXT  

Pulmonary Function in Long-Term Survivors of Testicular Cancer
Haugnes et al.
JCO 2009;27:2779-2786.
ABSTRACT | FULL TEXT  

Lung Cancer and Chronic Obstructive Pulmonary Disease: Needs and Opportunities for Integrated Research
Punturieri et al.
JNCI J Natl Cancer Inst 2009;101:554-559.
ABSTRACT | FULL TEXT  

Introduction.
Buist
Proc Am Thorac Soc 2008;5:796-799.
ABSTRACT | FULL TEXT  

Chronic Obstructive Pulmonary Disease with Lung Cancer and/or Cardiovascular Disease
Rodriguez-Roisin and Soriano
Proc Am Thorac Soc 2008;5:842-847.
ABSTRACT | FULL TEXT  

Lessons from Multidisciplinary Cross-Fertilization: Chronic Obstructive Pulmonary Disease, Lung Cancer, and Heart Disease
Rennard
Proc Am Thorac Soc 2008;5:865-868.
ABSTRACT | FULL TEXT  

Lung cancer gene associated with COPD: triple whammy or possible confounding effect?
Young et al.
Eur Respir J 2008;32:1158-1164.
ABSTRACT | FULL TEXT  

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Mannino et al.
Eur Respir J 2008;32:962-969.
ABSTRACT | FULL TEXT  

Association of Radiographic Emphysema and Airflow Obstruction with Lung Cancer
Wilson et al.
Am. J. Respir. Crit. Care Med. 2008;178:738-744.
ABSTRACT | FULL TEXT  

A Prediction Model for Lung Cancer Diagnosis that Integrates Genomic and Clinical Features
Beane et al.
Cancer Prevention Research 2008;1:56-64.
ABSTRACT | FULL TEXT  

Comorbidities in Chronic Obstructive Pulmonary Disease
Chatila et al.
Proc Am Thorac Soc 2008;5:549-555.
ABSTRACT | FULL TEXT  

Prevalence, severity and underdiagnosis of COPD in the primary care setting
Bednarek et al.
Thorax 2008;63:402-407.
ABSTRACT | FULL TEXT  

Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes
Young et al.
Eur Respir J 2007;30:616-622.
ABSTRACT | FULL TEXT  

COPD and Lung Cancer Have Come a Long Way ...Baby
Mannino
Am. J. Respir. Crit. Care Med. 2007;176:108-109.
FULL TEXT  

Inhaled Corticosteroids and Risk of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease
Parimon et al.
Am. J. Respir. Crit. Care Med. 2007;175:712-719.
ABSTRACT | FULL TEXT  

Computed Tomography Screening and Lung Cancer Outcomes
Bach et al.
JAMA 2007;297:953-961.
ABSTRACT | FULL TEXT  

Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers
Purdue et al.
Thorax 2007;62:51-56.
ABSTRACT | FULL TEXT  

Mortality in COPD: role of comorbidities
Sin et al.
Eur Respir J 2006;28:1245-1257.
ABSTRACT | FULL TEXT  

Spirometric screening: does it work?
Mannino
Thorax 2006;61:834-835.
FULL TEXT  

State of the Art. Chronic Obstructive Pulmonary Disease, Inflammation, and Lung Cancer
Brody and Spira
Proc Am Thorac Soc 2006;3:535-537.
ABSTRACT | FULL TEXT  

Lung function decline and outcomes in an elderly population
Mannino and Davis
Thorax 2006;61:472-477.
ABSTRACT | FULL TEXT  

The natural history of chronic obstructive pulmonary disease.
Mannino et al.
Eur Respir J 2006;27:627-643.
FULL TEXT  

Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers
Novello et al.
Ann Oncol 2005;16:1662-1666.
ABSTRACT | FULL TEXT  

Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis
Wasswa-Kintu et al.
Thorax 2005;60:570-575.
ABSTRACT | FULL TEXT  

Predictors of Lung Cancer among Asbestos-exposed Men in the {beta}-Carotene and Retinol Efficacy Trial
Cullen et al.
Am J Epidemiol 2005;161:260-270.
ABSTRACT | FULL TEXT  

Prognostic value of chronic obstructive pulmonary disease in 2994 cases of lung cancer
Lopez-Encuentra et al.
Eur. J. Cardiothorac. Surg. 2005;27:8-13.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.